Healthy Living/WellnessSarepta again seeks FDA approval for drug treating Duchenne muscular dystrophy Sarepta will file a new application for eteplirsen with the FDA. The eteplirsen drug will treat Duchenne muscular dystrophy, which affects young boys.by Anu Passary
Healthy Living/WellnessLab-grown human skin from stem cells may soon replace animals in cosmetic, drug testingby Anne Francis
Healthy Living/WellnessStatins: Cholesterol-lowering drug is America's excuse to pig out, says studyby Rhodi Lee
Healthy Living/WellnessWhat's 'beezin'? Teens try to get high using lip balm on eyelidsby Anne Francis
Healthy Living/WellnessThose extra cups of coffee might save you from having type 2 diabetes: Studyby Rhodi Lee
Healthy Living/WellnessWorld Malaria Day: India fights mosquitoes with guppy fish projectby Rhodi Lee
Healthy Living/WellnessFDA cracks down on e-cigarette industry through new proposed regulationsby Vamien McKalin
Healthy Living/WellnessDrug Take-Back Day happening this weekend-dump those old pills safelyby Judy Mottl
Healthy Living/WellnessKids on psych meds: How about 1 in 13 school kids taking themby Michael McEnaney
Healthy Living/WellnessVitamin D doesn't reduce or impact a person's fall risk, says new reportby Judy Mottl
Healthy Living/WellnessAspirin intake may lower colon cancer risks but it all depends on your DNAby Cez Verzosa
VP JD Vance Warns Heavy AI Regulation Could Kill Innovation, Vows U.S. Will Protect Free Speech at Paris Summit